Clinical Trial Update: Study With GW274150 In Patients With Mild Asthma [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry reports that a Phase 1 study of GW274150 in adults with mild asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW274150

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED